North America Ai-based Clinical Trials Solution Provider Market Size & Outlook

The ai-based clinical trials solution provider market in North America is expected to reach a projected revenue of US$ 2,647.4 million by 2030. A compound annual growth rate of 18.4% is expected of North America ai-based clinical trials solution provider market from 2022 to 2030.
Revenue, 2021 (US$M)
$578.0
Forecast, 2030 (US$M)
$2,647.4
CAGR, 2022 - 2030
18.4%
Report Coverage
North America

North America ai-based clinical trials solution provider market, 2018-2030 (US$M)

North

Related Markets

North America ai-based clinical trials solution provider market highlights

  • The North America ai-based clinical trials solution provider market generated a revenue of USD 578.0 million in 2021.
  • The market is expected to grow at a CAGR of 18.4% from 2022 to 2030.
  • In terms of segment, oncology was the largest revenue generating therapeutic applications in 2021.
  • CVD is the most lucrative therapeutic applications segment registering the fastest growth during the forecast period.
  • Country-wise, Canada is expected to register the highest CAGR from 2022 to 2030.


North America data book summary

Market revenue in 2021USD 578.0 million
Market revenue in 2030USD 2,647.4 million
Growth rate18.4% (CAGR from 2021 to 2030)
Largest segmentOncology
Fastest growing segmentCVD
Historical data covered2018 - 2020
Base year for estimation2021
Forecast period covered2022 - 2030
Quantitative unitsRevenue in USD million
Market segmentationOncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases
Key market players worldwideThe Carlyle Group Inc, Mendel.ai, Median Technologies, SAI.TECH Global Corp, Alphabet Inc Class A, Exscientia PLC ADR


Other key industry trends

  • In terms of revenue, North America region accounted for 43.8% of the global ai-based clinical trials solution provider market in 2021.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,944.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

AI-based Clinical Trials Solution Provider Market Companies

Name Profile # Employees HQ Website

North America ai-based clinical trials solution provider market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai-based clinical trials solution provider market will help companies and investors design strategic landscapes.


Oncology was the largest segment with a revenue share of 23.37% in 2021. Horizon Databook has segmented the North America ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.


North America dominated the market with the largest market share in 2020. It accounted for 43.6% of global AI-based clinical trials solution providers market owing to high R&D investments, rapid technological advancements, growing adoption of technologically advanced solutions, presence of global players, and their efforts to come up with newer patents.

In addition, there are high funding and growth opportunities for startups in the region, which is expected to promote market growth. For instance, in 2020, Unlearn.AI, a U.S.-based company, received series A funding by 8VC, a leading venture capital company, in the country.

This is expected to help Unlearn in expanding its reach and increasing its product portfolio. Such instances signify growth potential of the market. In addition, industry players are making advances in their efforts to decrease timelines by adopting advanced technologies.

Reasons to subscribe to North America ai-based clinical trials solution provider market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America ai-based clinical trials solution provider market databook

  • Our clientele includes a mix of ai-based clinical trials solution provider market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America ai-based clinical trials solution provider market, including forecasts for subscribers. This continent databook contains high-level insights into North America ai-based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America artificial intelligence based clinical trials solution provider market size, by country, 2018-2030 (US$M)

North America AI-based Clinical Trials Solution Provider Market Share, 2021 & 2030 (US$M)

North America artificial intelligence based clinical trials solution provider market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more